Rank | Gene Set | Z-score |
---|---|---|
1 | microglial cell activation (GO:0001774) | 6.94385323 |
2 | macrophage activation involved in immune response (GO:0002281) | 5.83923709 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.72399798 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.72399798 |
5 | modulation by symbiont of host immune response (GO:0052553) | 5.72399798 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.72399798 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.72399798 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.72399798 |
9 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.69961374 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.27398905 |
11 | cytidine deamination (GO:0009972) | 5.24858431 |
12 | cytidine metabolic process (GO:0046087) | 5.24858431 |
13 | cytidine catabolic process (GO:0006216) | 5.24858431 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.05077361 |
15 | B cell receptor signaling pathway (GO:0050853) | 4.87469753 |
16 | T cell migration (GO:0072678) | 4.75355625 |
17 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.72483863 |
18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.60636237 |
19 | negative regulation of cell killing (GO:0031342) | 4.60636237 |
20 | macrophage activation (GO:0042116) | 4.60175441 |
21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.59171925 |
22 | cellular response to interleukin-15 (GO:0071350) | 4.53859970 |
23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45596250 |
24 | positive regulation of chemokine secretion (GO:0090197) | 4.39917584 |
25 | regulation of gamma-delta T cell activation (GO:0046643) | 4.38276954 |
26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.33749597 |
27 | response to interleukin-15 (GO:0070672) | 4.33292537 |
28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.23454711 |
29 | cellular extravasation (GO:0045123) | 4.16735635 |
30 | B cell mediated immunity (GO:0019724) | 4.11734633 |
31 | DNA deamination (GO:0045006) | 4.05308862 |
32 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.05290179 |
33 | positive thymic T cell selection (GO:0045059) | 4.03609625 |
34 | negative thymic T cell selection (GO:0045060) | 4.00099705 |
35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.96987155 |
36 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.94990340 |
37 | positive regulation of interferon-alpha production (GO:0032727) | 3.90001726 |
38 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.89971175 |
39 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.89684076 |
40 | neutrophil activation involved in immune response (GO:0002283) | 3.86419109 |
41 | regulation of interferon-alpha production (GO:0032647) | 3.85247742 |
42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.84834376 |
43 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.84652597 |
44 | negative T cell selection (GO:0043383) | 3.84582430 |
45 | regulation of B cell differentiation (GO:0045577) | 3.80272920 |
46 | negative regulation of interleukin-12 production (GO:0032695) | 3.79304323 |
47 | detection of other organism (GO:0098543) | 3.78290730 |
48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.73434783 |
49 | detection of bacterium (GO:0016045) | 3.70242156 |
50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.67787110 |
51 | response to type I interferon (GO:0034340) | 3.66573210 |
52 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.65548160 |
53 | cellular response to type I interferon (GO:0071357) | 3.65437186 |
54 | type I interferon signaling pathway (GO:0060337) | 3.65437186 |
55 | glycosphingolipid catabolic process (GO:0046479) | 3.64344499 |
56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.60814464 |
57 | response to host (GO:0075136) | 3.60814464 |
58 | response to host defenses (GO:0052200) | 3.60814464 |
59 | B cell homeostasis (GO:0001782) | 3.58404883 |
60 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.58008305 |
61 | glycolipid catabolic process (GO:0019377) | 3.57933757 |
62 | myeloid cell activation involved in immune response (GO:0002275) | 3.57648584 |
63 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.55019614 |
64 | response to host immune response (GO:0052572) | 3.55019614 |
65 | T-helper 1 type immune response (GO:0042088) | 3.53858851 |
66 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.51239735 |
67 | negative regulation of granulocyte differentiation (GO:0030853) | 3.48290045 |
68 | oligosaccharide catabolic process (GO:0009313) | 3.46332673 |
69 | adenosine receptor signaling pathway (GO:0001973) | 3.44506057 |
70 | response to muramyl dipeptide (GO:0032495) | 3.43152572 |
71 | regulation of chemokine secretion (GO:0090196) | 3.41901594 |
72 | detection of external biotic stimulus (GO:0098581) | 3.41719648 |
73 | I-kappaB phosphorylation (GO:0007252) | 3.40959623 |
74 | positive regulation of antigen processing and presentation (GO:0002579) | 3.39201947 |
75 | regulation of mast cell degranulation (GO:0043304) | 3.39036055 |
76 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.37635026 |
77 | T cell costimulation (GO:0031295) | 3.35767399 |
78 | positive T cell selection (GO:0043368) | 3.34067080 |
79 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32460603 |
80 | lymphocyte costimulation (GO:0031294) | 3.31280651 |
81 | response to peptidoglycan (GO:0032494) | 3.29733143 |
82 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25563774 |
83 | keratan sulfate catabolic process (GO:0042340) | 3.24143879 |
84 | negative regulation of mast cell activation (GO:0033004) | 3.23196736 |
85 | respiratory burst (GO:0045730) | 3.22802056 |
86 | ceramide catabolic process (GO:0046514) | 3.22665269 |
87 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.21875172 |
88 | immunoglobulin mediated immune response (GO:0016064) | 3.21590835 |
89 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.20651480 |
90 | cellular response to interferon-gamma (GO:0071346) | 3.19118683 |
91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18784135 |
92 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.17981826 |
93 | thymic T cell selection (GO:0045061) | 3.17865932 |
94 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.17006168 |
95 | defense response to protozoan (GO:0042832) | 3.16970936 |
96 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15994088 |
97 | regulation of B cell proliferation (GO:0030888) | 3.15690880 |
98 | response to laminar fluid shear stress (GO:0034616) | 3.14964378 |
99 | purinergic receptor signaling pathway (GO:0035587) | 3.12503718 |
100 | positive regulation of defense response to virus by host (GO:0002230) | 3.10673075 |
101 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09204864 |
102 | hyaluronan catabolic process (GO:0030214) | 3.07404110 |
103 | angiogenesis involved in wound healing (GO:0060055) | 3.06496551 |
104 | T cell selection (GO:0045058) | 3.06342641 |
105 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.05797929 |
106 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.05797929 |
107 | positive regulation of humoral immune response (GO:0002922) | 3.03778445 |
108 | regulation of regulatory T cell differentiation (GO:0045589) | 3.03127211 |
109 | positive regulation of B cell differentiation (GO:0045579) | 3.03122533 |
110 | interferon-gamma production (GO:0032609) | 3.02624067 |
111 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.01064522 |
112 | regulation of T cell tolerance induction (GO:0002664) | 3.00380349 |
113 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.00202613 |
114 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.99767642 |
115 | granulocyte activation (GO:0036230) | 2.97702815 |
116 | detection of biotic stimulus (GO:0009595) | 2.97590636 |
117 | neutrophil activation (GO:0042119) | 2.96717806 |
118 | surfactant homeostasis (GO:0043129) | 2.93526843 |
119 | positive regulation of vasculogenesis (GO:2001214) | 2.93272107 |
120 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.92963962 |
121 | myeloid dendritic cell activation (GO:0001773) | 2.92635710 |
122 | regulation of mast cell activation (GO:0033003) | 2.92477030 |
123 | histamine secretion (GO:0001821) | 2.91768792 |
124 | myeloid leukocyte activation (GO:0002274) | 2.87351555 |
125 | negative regulation of interleukin-6 production (GO:0032715) | 2.87317079 |
126 | phagocytosis, engulfment (GO:0006911) | 2.85417111 |
127 | apoptotic cell clearance (GO:0043277) | 2.82842479 |
128 | negative regulation of B cell proliferation (GO:0030889) | 2.82739067 |
129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.82683325 |
130 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82350958 |
131 | germinal center formation (GO:0002467) | 2.80900809 |
132 | blood vessel maturation (GO:0001955) | 2.80229211 |
133 | chondroitin sulfate catabolic process (GO:0030207) | 2.79609133 |
134 | endothelium development (GO:0003158) | 2.79367571 |
135 | regulation of antigen processing and presentation (GO:0002577) | 2.79091344 |
136 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77022974 |
137 | regulation of leukocyte degranulation (GO:0043300) | 2.74909978 |
138 | mannose metabolic process (GO:0006013) | 2.74855389 |
139 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.74294487 |
140 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.74135588 |
141 | lymph vessel development (GO:0001945) | 2.73489747 |
142 | regulation of endothelial cell differentiation (GO:0045601) | 2.72886541 |
143 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.71992788 |
144 | protein kinase C signaling (GO:0070528) | 2.71067126 |
145 | monocyte differentiation (GO:0030224) | 2.69598896 |
146 | regulation of monocyte chemotaxis (GO:0090025) | 2.68760967 |
147 | macrophage chemotaxis (GO:0048246) | 2.67179660 |
148 | positive regulation of interferon-beta production (GO:0032728) | 2.65841386 |
149 | ruffle organization (GO:0031529) | 2.65765828 |
150 | response to interferon-beta (GO:0035456) | 2.64733412 |
151 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.64489184 |
152 | detection of molecule of bacterial origin (GO:0032490) | 2.60642166 |
153 | adaptation of signaling pathway (GO:0023058) | 2.59451964 |
154 | regulation of macrophage chemotaxis (GO:0010758) | 2.58255304 |
155 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57514881 |
156 | macrophage differentiation (GO:0030225) | 2.57462348 |
157 | neutrophil chemotaxis (GO:0030593) | 2.56200564 |
158 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.55057619 |
159 | leukocyte tethering or rolling (GO:0050901) | 2.53911776 |
160 | negative regulation of norepinephrine secretion (GO:0010700) | 2.53824545 |
161 | regulation of platelet activation (GO:0010543) | 2.51489099 |
162 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.51023892 |
163 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.50233680 |
164 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.49749315 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.45823728 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.53070402 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.48471674 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.31030255 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.04439305 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.02755818 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.15984905 |
8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15261703 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10539005 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94058798 |
11 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.89545206 |
12 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.77573738 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.74140382 |
14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65874351 |
15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.57887818 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42800890 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36758472 |
18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.36446296 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19912933 |
20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18001039 |
21 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16319397 |
22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.08215440 |
23 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04623298 |
24 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.04103313 |
25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93740680 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91190015 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87626759 |
28 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86497715 |
29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85476553 |
30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73390487 |
31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73147726 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71625638 |
33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.70140166 |
34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67514852 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67328414 |
36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63771875 |
37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63635570 |
38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62644843 |
39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.60764516 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56566809 |
41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53553876 |
42 | MAF_26560356_Chip-Seq_TH1_Human | 1.48733587 |
43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48288532 |
44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48234524 |
45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48109350 |
46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47907128 |
47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46657761 |
48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46354714 |
49 | MYC_22102868_ChIP-Seq_BL_Human | 1.43516823 |
50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39455647 |
51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39010537 |
52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37565806 |
53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35940948 |
54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35194417 |
55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.34886912 |
56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.34592299 |
57 | MYB_26560356_Chip-Seq_TH2_Human | 1.34436340 |
58 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.32481727 |
59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32434909 |
60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31441198 |
61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.29410121 |
62 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.29303047 |
63 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.29303047 |
64 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.29303047 |
65 | MYB_26560356_Chip-Seq_TH1_Human | 1.25425880 |
66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23842276 |
67 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21522170 |
68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21367367 |
69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20872580 |
70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19628338 |
71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17870948 |
72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15917242 |
73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14636277 |
74 | MAF_26560356_Chip-Seq_TH2_Human | 1.13701566 |
75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13337990 |
76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12575248 |
77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12043801 |
78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11763795 |
79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10532735 |
80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10121714 |
81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09783102 |
82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09674376 |
83 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09329396 |
84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08204716 |
85 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07532442 |
86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07422712 |
87 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06558756 |
88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04784108 |
89 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04356901 |
90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04311607 |
91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04278446 |
92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03677349 |
93 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03046013 |
94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02572251 |
95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02305368 |
96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02046682 |
97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01957249 |
98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99654448 |
99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99360319 |
100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97658125 |
101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96942670 |
102 | GATA3_26560356_Chip-Seq_TH1_Human | 0.96910380 |
103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96074745 |
104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95956954 |
105 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95952878 |
106 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95882356 |
107 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95063319 |
108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94374677 |
109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94253154 |
110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93516008 |
111 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92544180 |
112 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92330977 |
113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92207305 |
114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91055567 |
115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90776634 |
116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90368680 |
117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88891099 |
118 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88673282 |
119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88614867 |
120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88614867 |
121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88491597 |
122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87660730 |
123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87282907 |
124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87268287 |
125 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85307109 |
126 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.83684249 |
127 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80554782 |
128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79681658 |
129 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.79546283 |
130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74813555 |
131 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74786069 |
132 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.73978284 |
133 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73596052 |
134 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.73556280 |
135 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.73187516 |
136 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.72972447 |
137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.72241008 |
138 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71260509 |
139 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71118604 |
140 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.70709095 |
141 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.69252266 |
142 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68172579 |
143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66196187 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 3.96307535 |
2 | MP0003724_increased_susceptibility_to | 3.74923757 |
3 | MP0006082_CNS_inflammation | 3.71155127 |
4 | MP0003191_abnormal_cellular_cholesterol | 3.56139860 |
5 | MP0003303_peritoneal_inflammation | 3.35128064 |
6 | MP0001835_abnormal_antigen_presentation | 3.33699161 |
7 | MP0003172_abnormal_lysosome_physiology | 2.81221522 |
8 | MP0003763_abnormal_thymus_physiology | 2.67320545 |
9 | * MP0002419_abnormal_innate_immunity | 2.61711288 |
10 | MP0005671_abnormal_response_to | 2.58775793 |
11 | MP0003436_decreased_susceptibility_to | 2.54984626 |
12 | MP0010368_abnormal_lymphatic_system | 2.50044587 |
13 | MP0005167_abnormal_blood-brain_barrier | 2.38839573 |
14 | MP0003690_abnormal_glial_cell | 2.32592369 |
15 | MP0000569_abnormal_digit_pigmentation | 2.31729463 |
16 | MP0009785_altered_susceptibility_to | 2.28016116 |
17 | MP0000343_altered_response_to | 2.24571371 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.23446107 |
19 | * MP0005464_abnormal_platelet_physiology | 2.19953647 |
20 | MP0001879_abnormal_lymphatic_vessel | 2.18921861 |
21 | MP0005000_abnormal_immune_tolerance | 2.18475294 |
22 | MP0002452_abnormal_antigen_presenting | 2.16033126 |
23 | MP0002138_abnormal_hepatobiliary_system | 2.07172711 |
24 | MP0001851_eye_inflammation | 2.03408146 |
25 | MP0005025_abnormal_response_to | 1.99948099 |
26 | MP0008004_abnormal_stomach_pH | 1.95842258 |
27 | MP0001800_abnormal_humoral_immune | 1.93762261 |
28 | MP0006054_spinal_hemorrhage | 1.93274590 |
29 | MP0003828_pulmonary_edema | 1.92301895 |
30 | MP0004883_abnormal_blood_vessel | 1.92267125 |
31 | MP0002723_abnormal_immune_serum | 1.91460571 |
32 | MP0001533_abnormal_skeleton_physiology | 1.90567348 |
33 | MP0003300_gastrointestinal_ulcer | 1.88378966 |
34 | MP0001986_abnormal_taste_sensitivity | 1.81460570 |
35 | * MP0001819_abnormal_immune_cell | 1.75360555 |
36 | * MP0002420_abnormal_adaptive_immunity | 1.73660954 |
37 | MP0000767_abnormal_smooth_muscle | 1.71981571 |
38 | MP0003866_abnormal_defecation | 1.69260954 |
39 | MP0000465_gastrointestinal_hemorrhage | 1.67296077 |
40 | MP0003566_abnormal_cell_adhesion | 1.66205729 |
41 | MP0004510_myositis | 1.66078639 |
42 | MP0001790_abnormal_immune_system | 1.62463017 |
43 | MP0005387_immune_system_phenotype | 1.62463017 |
44 | * MP0003075_altered_response_to | 1.58929955 |
45 | * MP0000249_abnormal_blood_vessel | 1.52064941 |
46 | MP0002405_respiratory_system_inflammati | 1.51201756 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.51130482 |
48 | MP0002998_abnormal_bone_remodeling | 1.46982303 |
49 | MP0001845_abnormal_inflammatory_respons | 1.46207215 |
50 | MP0005166_decreased_susceptibility_to | 1.45087498 |
51 | MP0003279_aneurysm | 1.44975247 |
52 | MP0000685_abnormal_immune_system | 1.44764548 |
53 | MP0004272_abnormal_basement_membrane | 1.44135839 |
54 | MP0008469_abnormal_protein_level | 1.42391761 |
55 | MP0005164_abnormal_response_to | 1.40224128 |
56 | MP0000703_abnormal_thymus_morphology | 1.39737966 |
57 | MP0004947_skin_inflammation | 1.39577695 |
58 | MP0009278_abnormal_bone_marrow | 1.39258217 |
59 | MP0003448_altered_tumor_morphology | 1.36229719 |
60 | MP0004381_abnormal_hair_follicle | 1.34298200 |
61 | MP0005645_abnormal_hypothalamus_physiol | 1.29683793 |
62 | MP0008438_abnormal_cutaneous_collagen | 1.29675516 |
63 | MP0005023_abnormal_wound_healing | 1.25077827 |
64 | MP0001853_heart_inflammation | 1.23484047 |
65 | MP0002254_reproductive_system_inflammat | 1.22816635 |
66 | MP0009840_abnormal_foam_cell | 1.22628817 |
67 | MP0005075_abnormal_melanosome_morpholog | 1.20067009 |
68 | MP0000716_abnormal_immune_system | 1.19632677 |
69 | MP0002166_altered_tumor_susceptibility | 1.18638145 |
70 | MP0001958_emphysema | 1.18204323 |
71 | MP0010155_abnormal_intestine_physiology | 1.14242202 |
72 | MP0004782_abnormal_surfactant_physiolog | 1.10788646 |
73 | MP0002277_abnormal_respiratory_mucosa | 1.08941047 |
74 | MP0000689_abnormal_spleen_morphology | 1.07684434 |
75 | MP0001915_intracranial_hemorrhage | 1.06675578 |
76 | MP0003453_abnormal_keratinocyte_physiol | 1.04275356 |
77 | MP0002396_abnormal_hematopoietic_system | 1.03878059 |
78 | MP0009764_decreased_sensitivity_to | 1.03303391 |
79 | * MP0002398_abnormal_bone_marrow | 1.01219833 |
80 | MP0005670_abnormal_white_adipose | 0.98572651 |
81 | MP0000858_altered_metastatic_potential | 0.98327520 |
82 | MP0003183_abnormal_peptide_metabolism | 0.96124343 |
83 | MP0005174_abnormal_tail_pigmentation | 0.95471202 |
84 | * MP0002429_abnormal_blood_cell | 0.95296589 |
85 | MP0000015_abnormal_ear_pigmentation | 0.94354134 |
86 | MP0005390_skeleton_phenotype | 0.93692139 |
87 | MP0002006_tumorigenesis | 0.93329590 |
88 | MP0003646_muscle_fatigue | 0.92055349 |
89 | MP0002722_abnormal_immune_system | 0.91860281 |
90 | * MP0003045_fibrosis | 0.91357956 |
91 | MP0002163_abnormal_gland_morphology | 0.90358482 |
92 | MP0002933_joint_inflammation | 0.90110766 |
93 | MP0002693_abnormal_pancreas_physiology | 0.87822840 |
94 | MP0001873_stomach_inflammation | 0.87753223 |
95 | MP0002295_abnormal_pulmonary_circulatio | 0.86938414 |
96 | MP0004084_abnormal_cardiac_muscle | 0.86647165 |
97 | MP0000372_irregular_coat_pigmentation | 0.86383544 |
98 | MP0005397_hematopoietic_system_phenotyp | 0.83386605 |
99 | MP0001545_abnormal_hematopoietic_system | 0.83386605 |
100 | MP0005423_abnormal_somatic_nervous | 0.83087071 |
101 | * MP0005165_increased_susceptibility_to | 0.80898864 |
102 | MP0000371_diluted_coat_color | 0.79160227 |
103 | MP0003091_abnormal_cell_migration | 0.78944415 |
104 | MP0009384_cardiac_valve_regurgitation | 0.77486308 |
105 | MP0005595_abnormal_vascular_smooth | 0.76637423 |
106 | MP0003195_calcinosis | 0.74756345 |
107 | MP0003795_abnormal_bone_structure | 0.74443189 |
108 | MP0000920_abnormal_myelination | 0.74405377 |
109 | MP0001663_abnormal_digestive_system | 0.74016171 |
110 | MP0005379_endocrine/exocrine_gland_phen | 0.73314079 |
111 | MP0002090_abnormal_vision | 0.71146697 |
112 | MP0002928_abnormal_bile_duct | 0.69892830 |
113 | MP0001614_abnormal_blood_vessel | 0.69216751 |
114 | MP0009763_increased_sensitivity_to | 0.68863276 |
115 | MP0000604_amyloidosis | 0.66849739 |
116 | MP0001542_abnormal_bone_strength | 0.66064066 |
117 | MP0008873_increased_physiological_sensi | 0.65513805 |
118 | MP0005310_abnormal_salivary_gland | 0.64789424 |
119 | MP0003638_abnormal_response/metabolism_ | 0.64626947 |
120 | MP0003252_abnormal_bile_duct | 0.64193208 |
121 | MP0010307_abnormal_tumor_latency | 0.63502697 |
122 | MP0002019_abnormal_tumor_incidence | 0.63496392 |
123 | MP0001348_abnormal_lacrimal_gland | 0.62197180 |
124 | MP0002009_preneoplasia | 0.61806241 |
125 | MP0002136_abnormal_kidney_physiology | 0.61117574 |
126 | MP0009765_abnormal_xenobiotic_induced | 0.60762441 |
127 | MP0008872_abnormal_physiological_respon | 0.52525834 |
128 | MP0002095_abnormal_skin_pigmentation | 0.51374391 |
129 | MP0008057_abnormal_DNA_replication | 0.51073977 |
130 | MP0002876_abnormal_thyroid_physiology | 0.49957980 |
131 | MP0008874_decreased_physiological_sensi | 0.47360461 |
132 | MP0001501_abnormal_sleep_pattern | 0.45833514 |
133 | MP0008877_abnormal_DNA_methylation | 0.45727790 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 7.02846884 |
2 | Glomerulonephritis (HP:0000099) | 5.25627160 |
3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.19235748 |
4 | Recurrent abscess formation (HP:0002722) | 5.07358771 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.04410085 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.04410085 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.04410085 |
8 | Eczematoid dermatitis (HP:0000976) | 4.77723149 |
9 | Agammaglobulinemia (HP:0004432) | 4.74554522 |
10 | Recurrent cutaneous fungal infections (HP:0011370) | 4.71961213 |
11 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.71961213 |
12 | Meningitis (HP:0001287) | 4.68711838 |
13 | Dysostosis multiplex (HP:0000943) | 4.52836623 |
14 | Abnormality of T cell number (HP:0011839) | 4.46815547 |
15 | Recurrent bacterial skin infections (HP:0005406) | 4.45856022 |
16 | T lymphocytopenia (HP:0005403) | 4.32799120 |
17 | Vacuolated lymphocytes (HP:0001922) | 4.32730810 |
18 | Vasculitis (HP:0002633) | 4.30464186 |
19 | Recurrent bronchitis (HP:0002837) | 4.30003759 |
20 | Pulmonary artery stenosis (HP:0004415) | 4.13661858 |
21 | Gastrointestinal stroma tumor (HP:0100723) | 4.11244266 |
22 | Increased cerebral lipofuscin (HP:0011813) | 4.02689924 |
23 | Abnormality of T cells (HP:0002843) | 3.96104298 |
24 | IgG deficiency (HP:0004315) | 3.96103759 |
25 | Arterial tortuosity (HP:0005116) | 3.92614547 |
26 | Recurrent sinusitis (HP:0011108) | 3.90287597 |
27 | Recurrent viral infections (HP:0004429) | 3.89782423 |
28 | Complement deficiency (HP:0004431) | 3.87915271 |
29 | Panhypogammaglobulinemia (HP:0003139) | 3.85950656 |
30 | Adactyly (HP:0009776) | 3.80541609 |
31 | Hematochezia (HP:0002573) | 3.80517567 |
32 | IgA deficiency (HP:0002720) | 3.80351346 |
33 | Duplicated collecting system (HP:0000081) | 3.75996146 |
34 | IgM deficiency (HP:0002850) | 3.71196100 |
35 | Vascular tortuosity (HP:0004948) | 3.69456103 |
36 | Pulmonary infiltrates (HP:0002113) | 3.67372456 |
37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.62649978 |
38 | Encephalitis (HP:0002383) | 3.61097062 |
39 | Abnormality of T cell physiology (HP:0011840) | 3.57892820 |
40 | Stomatitis (HP:0010280) | 3.57418725 |
41 | Cerebral aneurysm (HP:0004944) | 3.56811441 |
42 | Lymphopenia (HP:0001888) | 3.55883867 |
43 | Abnormality of macrophages (HP:0004311) | 3.50155588 |
44 | Aortic aneurysm (HP:0004942) | 3.49234305 |
45 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.48666284 |
46 | Abnormality of the prostate (HP:0008775) | 3.48342774 |
47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.45797566 |
48 | Long foot (HP:0001833) | 3.39585577 |
49 | Spontaneous hematomas (HP:0007420) | 3.33833085 |
50 | Hemoptysis (HP:0002105) | 3.27240679 |
51 | J-shaped sella turcica (HP:0002680) | 3.21813790 |
52 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.16349227 |
53 | Mucopolysacchariduria (HP:0008155) | 3.16349227 |
54 | Abnormality of complement system (HP:0005339) | 3.15088773 |
55 | Gastrointestinal infarctions (HP:0005244) | 3.13751697 |
56 | Hepatosplenomegaly (HP:0001433) | 3.07668398 |
57 | Abnormality of the renal collecting system (HP:0004742) | 3.07158755 |
58 | Axonal loss (HP:0003447) | 3.06861898 |
59 | Myositis (HP:0100614) | 3.06375739 |
60 | Nephritis (HP:0000123) | 3.05570704 |
61 | Colitis (HP:0002583) | 3.01989717 |
62 | Autoimmune hemolytic anemia (HP:0001890) | 3.00863627 |
63 | Spondylolisthesis (HP:0003302) | 3.00788690 |
64 | Chest pain (HP:0100749) | 3.00069607 |
65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92205288 |
66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92205288 |
67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92205288 |
68 | Thick nail (HP:0001805) | 2.91466908 |
69 | Interstitial pulmonary disease (HP:0006530) | 2.91215349 |
70 | Increased IgM level (HP:0003496) | 2.89706704 |
71 | Restrictive lung disease (HP:0002091) | 2.86697432 |
72 | Abnormality of the pleura (HP:0002103) | 2.84652420 |
73 | Orchitis (HP:0100796) | 2.74866758 |
74 | Urticaria (HP:0001025) | 2.74675143 |
75 | Disinhibition (HP:0000734) | 2.74236782 |
76 | Keratoconjunctivitis (HP:0001096) | 2.72586722 |
77 | Abnormality of B cell number (HP:0010975) | 2.69163391 |
78 | Large for gestational age (HP:0001520) | 2.67262941 |
79 | Aortic dissection (HP:0002647) | 2.66641953 |
80 | Recurrent skin infections (HP:0001581) | 2.66317616 |
81 | Mutism (HP:0002300) | 2.65932080 |
82 | Autoimmune thrombocytopenia (HP:0001973) | 2.63552188 |
83 | Abnormal platelet function (HP:0011869) | 2.55368089 |
84 | Impaired platelet aggregation (HP:0003540) | 2.55368089 |
85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54377556 |
86 | Chronic otitis media (HP:0000389) | 2.53006764 |
87 | Recurrent pneumonia (HP:0006532) | 2.51949905 |
88 | Abnormality of eosinophils (HP:0001879) | 2.50588647 |
89 | Cervical subluxation (HP:0003308) | 2.48614512 |
90 | Gangrene (HP:0100758) | 2.44576467 |
91 | Recurrent fungal infections (HP:0002841) | 2.42807806 |
92 | Retinal atrophy (HP:0001105) | 2.42207504 |
93 | Emphysema (HP:0002097) | 2.42004061 |
94 | Pulmonary embolism (HP:0002204) | 2.40833432 |
95 | Bronchitis (HP:0012387) | 2.40573200 |
96 | Thyroiditis (HP:0100646) | 2.39414644 |
97 | Lymphoma (HP:0002665) | 2.39147842 |
98 | Recurrent lower respiratory tract infections (HP:0002783) | 2.37858484 |
99 | Prostate neoplasm (HP:0100787) | 2.36635074 |
100 | Inflammation of the large intestine (HP:0002037) | 2.36471981 |
101 | Severe combined immunodeficiency (HP:0004430) | 2.35855989 |
102 | Obstructive lung disease (HP:0006536) | 2.35198100 |
103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35198100 |
104 | Retrobulbar optic neuritis (HP:0100654) | 2.34713886 |
105 | Optic neuritis (HP:0100653) | 2.34713886 |
106 | Broad face (HP:0000283) | 2.33770862 |
107 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.33618051 |
108 | Gingivitis (HP:0000230) | 2.31097748 |
109 | Hypoplastic nipples (HP:0002557) | 2.30985901 |
110 | Eosinophilia (HP:0001880) | 2.30860354 |
111 | Skin rash (HP:0000988) | 2.29601774 |
112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29121262 |
113 | Osteolytic defects of the hand bones (HP:0009699) | 2.29121262 |
114 | Myocardial infarction (HP:0001658) | 2.29061529 |
115 | Mediastinal lymphadenopathy (HP:0100721) | 2.27145377 |
116 | Hemorrhage of the eye (HP:0011885) | 2.27096864 |
117 | Progressive neurologic deterioration (HP:0002344) | 2.24820068 |
118 | Premature loss of primary teeth (HP:0006323) | 2.24801546 |
119 | Increased IgE level (HP:0003212) | 2.23170040 |
120 | Ureteral obstruction (HP:0006000) | 2.22878394 |
121 | B lymphocytopenia (HP:0010976) | 2.22120928 |
122 | Acute lymphatic leukemia (HP:0006721) | 2.20092518 |
123 | Abnormality of the nasal mucosa (HP:0000433) | 2.18547636 |
124 | Striae distensae (HP:0001065) | 2.17940334 |
125 | Ureteral stenosis (HP:0000071) | 2.17938972 |
126 | Disproportionate tall stature (HP:0001519) | 2.15565169 |
127 | Abnormality of male internal genitalia (HP:0000022) | 2.15390081 |
128 | Viral hepatitis (HP:0006562) | 2.14633283 |
129 | Arthralgia (HP:0002829) | 2.11979607 |
130 | Amaurosis fugax (HP:0100576) | 2.11792450 |
131 | Deformed sella turcica (HP:0002681) | 2.11512148 |
132 | Leukocytosis (HP:0001974) | 2.11397621 |
133 | Joint stiffness (HP:0001387) | 2.10865229 |
134 | Papilloma (HP:0012740) | 2.10848708 |
135 | Verrucae (HP:0200043) | 2.10848708 |
136 | Cellulitis (HP:0100658) | 2.09515519 |
137 | Gastrointestinal inflammation (HP:0004386) | 2.08875571 |
138 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08711843 |
139 | Joint swelling (HP:0001386) | 2.07081273 |
140 | Agnosia (HP:0010524) | 2.07017541 |
141 | Stomach cancer (HP:0012126) | 2.07010850 |
142 | Joint hemorrhage (HP:0005261) | 2.06977428 |
143 | Facial diplegia (HP:0001349) | 2.05942486 |
144 | Hypochromic anemia (HP:0001931) | 2.05726703 |
145 | Pathologic fracture (HP:0002756) | 2.05588744 |
146 | Hemiplegia (HP:0002301) | 2.03755726 |
147 | Pulmonary fibrosis (HP:0002206) | 2.03506633 |
148 | Arterial thrombosis (HP:0004420) | 2.02059098 |
149 | Epistaxis (HP:0000421) | 2.01569853 |
150 | Chronic diarrhea (HP:0002028) | 1.99640360 |
151 | Sepsis (HP:0100806) | 1.98860474 |
152 | Palmoplantar hyperkeratosis (HP:0000972) | 1.98510196 |
153 | Purpura (HP:0000979) | 1.97736727 |
154 | Thoracic kyphosis (HP:0002942) | 1.94899381 |
155 | Chronic sinusitis (HP:0011109) | 1.93283711 |
156 | Conjunctival telangiectasia (HP:0000524) | 1.93120603 |
157 | Pustule (HP:0200039) | 1.93022211 |
158 | Granulocytopenia (HP:0001913) | 1.93012726 |
159 | Thickened calvaria (HP:0002684) | 1.92836295 |
160 | Hypergammaglobulinemia (HP:0010702) | 1.92635264 |
161 | Polyneuropathy (HP:0001271) | 1.91621214 |
162 | Keratoconjunctivitis sicca (HP:0001097) | 1.91253108 |
163 | Leukopenia (HP:0001882) | 1.90871336 |
164 | Esophageal varix (HP:0002040) | 1.90745671 |
165 | Combined immunodeficiency (HP:0005387) | 1.90102078 |
166 | Palmar hyperkeratosis (HP:0010765) | 1.88948184 |
167 | Osteomyelitis (HP:0002754) | 1.88419095 |
168 | Anorexia (HP:0002039) | 1.87854055 |
169 | Hypoplasia of the thymus (HP:0000778) | 1.85317314 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 7.88676430 |
2 | GRK7 | 3.48074284 |
3 | TIE1 | 3.16499258 |
4 | MAPK15 | 3.00432944 |
5 | STK10 | 2.57311359 |
6 | TYK2 | 2.50111088 |
7 | CSF1R | 2.44748543 |
8 | KDR | 2.37426125 |
9 | IRAK4 | 2.37097016 |
10 | FRK | 2.32197788 |
11 | IRAK3 | 2.12625575 |
12 | TBK1 | 2.00659095 |
13 | MAP3K14 | 1.99813506 |
14 | RIPK4 | 1.97610995 |
15 | KIT | 1.89587992 |
16 | PAK4 | 1.87324132 |
17 | BLK | 1.85016770 |
18 | PDK2 | 1.77859878 |
19 | ERN1 | 1.75646458 |
20 | MAP3K13 | 1.72507514 |
21 | CLK1 | 1.67971218 |
22 | MAP4K1 | 1.64598660 |
23 | CSK | 1.62273046 |
24 | EPHB1 | 1.60444750 |
25 | MOS | 1.58237586 |
26 | FES | 1.55691364 |
27 | PRKCQ | 1.53013180 |
28 | JAK1 | 1.52915848 |
29 | ZAP70 | 1.40238399 |
30 | TXK | 1.28220576 |
31 | RIPK1 | 1.26312411 |
32 | HCK | 1.25748739 |
33 | IKBKB | 1.22798927 |
34 | CAMK1D | 1.21221843 |
35 | NUAK1 | 1.19837085 |
36 | GRK6 | 1.18043749 |
37 | GRK5 | 1.16196543 |
38 | TLK1 | 1.14712684 |
39 | EIF2AK3 | 1.11923305 |
40 | SIK2 | 1.10919291 |
41 | MAP2K3 | 1.09708552 |
42 | IKBKE | 1.09334800 |
43 | TNK2 | 1.06876872 |
44 | CDC42BPA | 1.05628998 |
45 | MAPK12 | 1.03426263 |
46 | IRAK1 | 1.01936088 |
47 | TEC | 0.99941114 |
48 | JAK3 | 0.99652267 |
49 | PTK6 | 0.99584481 |
50 | ACVR1B | 0.99338768 |
51 | PIK3CG | 0.99228756 |
52 | JAK2 | 0.96053649 |
53 | MAPK7 | 0.94040439 |
54 | MATK | 0.92645318 |
55 | LYN | 0.90741189 |
56 | STK24 | 0.89702922 |
57 | LCK | 0.88235926 |
58 | ITK | 0.87777510 |
59 | DAPK2 | 0.87398694 |
60 | CAMK1G | 0.87276598 |
61 | PIM2 | 0.87038502 |
62 | PTK2B | 0.85187434 |
63 | FGR | 0.79199905 |
64 | MYLK | 0.78101475 |
65 | CDK19 | 0.77474091 |
66 | NEK9 | 0.75836361 |
67 | MAP3K6 | 0.74807825 |
68 | DMPK | 0.72164903 |
69 | EIF2AK2 | 0.72151834 |
70 | PIM1 | 0.69412911 |
71 | TGFBR1 | 0.69075013 |
72 | FGFR3 | 0.69014667 |
73 | OXSR1 | 0.68050429 |
74 | FGFR4 | 0.67585327 |
75 | IGF1R | 0.66193913 |
76 | PDK1 | 0.65955297 |
77 | BTK | 0.65755000 |
78 | MST4 | 0.64734452 |
79 | SMG1 | 0.64077629 |
80 | BMPR1B | 0.63958262 |
81 | SYK | 0.61707158 |
82 | PAK2 | 0.60376172 |
83 | PKN2 | 0.59557628 |
84 | MAPK13 | 0.58952727 |
85 | PRPF4B | 0.58680392 |
86 | MAP3K3 | 0.58041950 |
87 | MARK3 | 0.57655789 |
88 | LRRK2 | 0.57300189 |
89 | TAOK3 | 0.56538214 |
90 | MAPKAPK2 | 0.55526616 |
91 | ARAF | 0.55450227 |
92 | VRK1 | 0.55290326 |
93 | EGFR | 0.54847604 |
94 | PRKCD | 0.54090347 |
95 | TTN | 0.54049592 |
96 | PRKCH | 0.52629571 |
97 | ZAK | 0.52181555 |
98 | MAPK11 | 0.51957502 |
99 | EPHA3 | 0.50870587 |
100 | TRPM7 | 0.50256569 |
101 | GSK3A | 0.50073203 |
102 | PDPK1 | 0.49344631 |
103 | CCNB1 | 0.48127192 |
104 | FYN | 0.47513572 |
105 | CHUK | 0.46800077 |
106 | TAF1 | 0.46328410 |
107 | TSSK6 | 0.46303150 |
108 | ABL1 | 0.45930296 |
109 | MELK | 0.45663312 |
110 | MAP3K7 | 0.45100744 |
111 | MAPKAPK5 | 0.44421898 |
112 | SGK2 | 0.44121156 |
113 | PRKD1 | 0.43516461 |
114 | SIK3 | 0.42688113 |
115 | GRK1 | 0.41794463 |
116 | PDGFRB | 0.41460483 |
117 | MAPKAPK3 | 0.40649094 |
118 | TRIB3 | 0.40325783 |
119 | RPS6KA4 | 0.39210352 |
120 | MAP2K2 | 0.38951162 |
121 | CAMKK2 | 0.38933523 |
122 | ADRBK2 | 0.38412893 |
123 | NEK6 | 0.36986153 |
124 | MAP2K6 | 0.35897121 |
125 | INSR | 0.35569805 |
126 | STK11 | 0.34925902 |
127 | HIPK2 | 0.34736750 |
128 | CDK3 | 0.32351850 |
129 | STK38L | 0.32101762 |
130 | CDK8 | 0.32046104 |
131 | MAP3K5 | 0.31851674 |
132 | PRKG2 | 0.30552274 |
133 | TNIK | 0.29490118 |
134 | BMPR2 | 0.29445948 |
135 | NLK | 0.28799183 |
136 | YES1 | 0.28436228 |
137 | PASK | 0.28431691 |
138 | MAPK4 | 0.27770757 |
139 | ROCK2 | 0.27431032 |
140 | CDK6 | 0.26009464 |
141 | RPS6KA6 | 0.25965008 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.27297548 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.85603509 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.79759821 |
4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.53752046 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75585193 |
6 | Lysosome_Homo sapiens_hsa04142 | 2.71194743 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.60305229 |
8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.51898046 |
9 | Pertussis_Homo sapiens_hsa05133 | 2.32089596 |
10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.11016953 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93425998 |
12 | Malaria_Homo sapiens_hsa05144 | 1.90721421 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87017275 |
14 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.78517907 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73427689 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72719485 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.69333947 |
18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67475474 |
19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66508502 |
20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62008192 |
21 | Legionellosis_Homo sapiens_hsa05134 | 1.58126838 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57734533 |
23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.54161928 |
24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53710733 |
25 | Prion diseases_Homo sapiens_hsa05020 | 1.43498464 |
26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.43465628 |
27 | Phagosome_Homo sapiens_hsa04145 | 1.41293202 |
28 | Salmonella infection_Homo sapiens_hsa05132 | 1.40514617 |
29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39349215 |
30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32445685 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31116516 |
32 | Measles_Homo sapiens_hsa05162 | 1.29632057 |
33 | Platelet activation_Homo sapiens_hsa04611 | 1.29406120 |
34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28656739 |
35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28445946 |
36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20385797 |
37 | Influenza A_Homo sapiens_hsa05164 | 1.17690386 |
38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17089732 |
39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15895791 |
40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15674187 |
41 | Apoptosis_Homo sapiens_hsa04210 | 1.07136860 |
42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05249035 |
43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01439711 |
44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01091453 |
45 | Shigellosis_Homo sapiens_hsa05131 | 0.98128132 |
46 | Allograft rejection_Homo sapiens_hsa05330 | 0.95968085 |
47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95352949 |
48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90844339 |
49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89116627 |
50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88032879 |
51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88026351 |
52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86322458 |
53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86244276 |
54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.83598784 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 0.83298656 |
56 | Adherens junction_Homo sapiens_hsa04520 | 0.82943622 |
57 | Amoebiasis_Homo sapiens_hsa05146 | 0.82850125 |
58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82338536 |
59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81660903 |
60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81506081 |
61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81203767 |
62 | Focal adhesion_Homo sapiens_hsa04510 | 0.77820766 |
63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74452372 |
64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74166460 |
65 | Endocytosis_Homo sapiens_hsa04144 | 0.70565440 |
66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69013467 |
67 | Asthma_Homo sapiens_hsa05310 | 0.67283110 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 0.66930248 |
69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64832984 |
70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64395046 |
71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64288022 |
72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61707873 |
73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59373283 |
74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57525783 |
75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57089373 |
76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56018482 |
77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50565885 |
78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49960596 |
79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49066860 |
80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47303903 |
81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46868843 |
82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46783369 |
83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46666662 |
84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46144769 |
85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44551488 |
86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42857534 |
87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40865710 |
88 | Mineral absorption_Homo sapiens_hsa04978 | 0.40265755 |
89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39739858 |
90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38794258 |
91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38099224 |
92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38060793 |
93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37421354 |
94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36791142 |
95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35210825 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35209024 |
97 | Renin secretion_Homo sapiens_hsa04924 | 0.34298917 |
98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31418228 |
99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30954861 |
100 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30265986 |
101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30160852 |
102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29519514 |
103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29296122 |
104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28643659 |
105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27785462 |
106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26879523 |
107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26836970 |
108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26383810 |
109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26203084 |
110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.25874164 |
111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25767601 |
112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21080300 |
113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20574970 |
114 | Homologous recombination_Homo sapiens_hsa03440 | 0.20490542 |
115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19291168 |
116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19245568 |
117 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.18774395 |
118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16631461 |
119 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.16285313 |
120 | Phototransduction_Homo sapiens_hsa04744 | 0.14369803 |
121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.08778056 |
122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07898988 |
123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.07351954 |
124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07280840 |
125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.06224535 |
126 | Insulin resistance_Homo sapiens_hsa04931 | 0.04217705 |
127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03863174 |
128 | Morphine addiction_Homo sapiens_hsa05032 | 0.02007721 |
129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.01779001 |
130 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.01218440 |
131 | Olfactory transduction_Homo sapiens_hsa04740 | 0.01112759 |